MAYNE PHARMA GROUP LIMITED revenue breakdown overview

MAYNE PHARMA GROUP LIMITED revenue for the last year amounted to 388.40 M AUD, the most of which — 174.86 M AUD — came from its highest performing source at the moment, Dermatology, the year earlier bringing 56.99 M AUD. The greatest contribution to the revenue figure was made by United States — last year it brought MAYNE PHARMA GROUP LIMITED 322.13 M AUD, and the year before that — 124.46 M AUD.